These vaccines deliver genetic material—either plasmid DNA or messenger RNA (mRNA)—encoding specific tumor antigens, sometimes alongside immunostimulatory molecules such as cytokines (e.g., IL-2, IL-12, GM-CSF), to promote robust and durable immune activation. This evidence concerns the gene CSF2 and neoplasm.